AvantGuard
PrivateLast Round
Seed
Jun 24, 2026
Total Funding Raised
$14.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AvantGuard is a healthcare company that develops antimicrobial technologies, including its flagship molecule Avantamine, designed to combat pathogens on surfaces and skin.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Sustainable Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AvantGuard Comparables
Compare AvantGuard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kismet Technologies | 79% | |
| Allied BioScience | 79% | |
| Kastus Technologies | 62% |
AvantGuard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2026 | ||||
| Grant | Nov 10, 2025 | ||||
| Grant | Jun 7, 2023 | ||||
| Seed | May 11, 2023 | ||||
| Grant | Apr 19, 2023 | ||||
Grant | Sep 29, 2022 |
AvantGuard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Launch NY | Seed |
| NIH RADx | Grant |
| Blue Ledge Capital | Seed |
| Empire State Development | Grant |
| FuzeHub | Grant |
| Red Bear Ventures | Seed, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 64% MoM.
- Jun 24, 2026
$1.7M seed round completed.
AvantGuard Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AvantGuard's valuation, stock price, and market status.
Is AvantGuard a public or private company?
AvantGuard is a private company.
What is the current stock price of AvantGuard?
AvantGuard is a private company with no public stock price. No recent secondary market data is available.
How much is AvantGuard worth (valuation)?
Valuation information for AvantGuard is not publicly available.
Can I buy AvantGuard stock?
AvantGuard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AvantGuard's last funding round?
AvantGuard's most recent funding round was Grant on June 7, 2023.
Who are the main investors in AvantGuard?
Key investors in AvantGuard include Blue Ledge Capital.
Will AvantGuard IPO soon?
No public IPO plans have been announced for AvantGuard.
How can I track AvantGuard secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AvantGuard's secondary market activity and sign up for updates.